|
Market Closed -
Nasdaq
04:00:00 2026-09-14 pm EDT
|
5-day change | 1st Jan Change | ||
| 381.50 USD | +1.10% |
|
-12.75% | +16.56% |
| Sep. 14 | Amgen Gets FDA Approval to Reduce Monitoring Time for First Two Imdelltra Doses | MT |
| Sep. 14 | Amgen Receives FDA Approval for Reduced Monitoring Time for First Two Doses of Imdelltra | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- AMGN Stock
- Consensus Amgen Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
